Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Nova (NasdaqGS:NVMI) with a Overweight ...

Cantor Fitzgerald raised the firm’s price target on MicroStrategy (MSTR) to $613 from $581 and keeps an Overweight rating on the shares.

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

Cantor Fitzgerald downgraded Intra-Cellular (ITCI) to Neutral from Overweight with a price target of $132, down from $135, after Johnson & ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

Cantor Fitzgerald assumed coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research note published on Friday morning, Marketbeat reports. The firm issued an overweight ...

WASHINGTON, Dec 12 (Reuters) - Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75 million penalty to settle Securities and Exchange Commission charges that it misled investors in ...

Analysts at Cantor Fitzgerald initiated coverage on shares of Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report) in a note issued to investors on Friday, MarketBeat.com reports. The brokerage ...

Cantor Fitzgerald International Eq Fund earns an Above Average Process Pillar rating. The primary contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90%.

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...